In The News

In Law360, Life Sciences Co-Chair Addresses Life Sciences Dealmaking Climate ahead of JP Morgan Healthcare Conference

Practices: Health Care, Mergers & Acquisitions, Health Care Finance & Restructuring, Life Sciences Licensing, Collaborations & Joint Ventures, China Life Sciences, Digital Health

Life sciences partner Michael Beauvais (Boston) analyzed the transactions climate in a 2019 JP Morgan Healthcare Conference preview article published Jan. 4 in Law360.

Mr. Beauvais explains that the life sciences industry is starting to shift in market mood, from bullish to cautionary. He predicts an increase in incremental deals, such as bolt-on acquisitions, as well as more carveout divestitures, where companies sell off non-core assets to other strategics as well as private equity.

Cookie Settings